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ABSTRACT
Introduction: Fractional flow reserve (FFR) is
recommended by society guidelines for
assessment of the hemodynamic significance of
intermediate coronary lesionswhennon-invasive
evidence of myocardial ischemia is unavailable.
However, the prevalence of FFR usage in current
practice and how FFR values impact
revascularization decisions are not well known.
Methods: At a single-center Veterans
Administration Hospital, all subjects referred
for coronary angiography for any indication
from the period from May 2012 until January
2014 were prospectively entered into a
database. FFR was measured in all intermediate
coronary lesions (30–70% stenosis). Based on
the FFR results, the lesions were categorized into
3 different groups: FFR[0.80 (non-ischemic),
FFR 0.75–0.80 (gray zone), and FFR\0.75
(ischemic).
Results: A total of 1482 cardiac catheterizations
were performed during the study period. FFR
was performed in 347 (23%) of these
procedures. The total numbers of intermediate
coronary lesions evaluated with FFR were 429.
The mean FFR value was 0.79 (median = 0.80;
interquartile range 0.64–0.96). Among 211
non-ischemic lesions, revascularization was
deferred in 201 (95%). In the gray-zone group
(73 lesions), 35 (48%) lesions were treated with
percutaneous coronary intervention (PCI), 11
(15%) lesions were referred for coronary artery
bypass grafting surgery (CABG), and 27 (37%)
lesions were treated medically. In the ischemic
group (145 lesions), 82 (57%) lesions were
treated with PCI, 41 (28%) lesions were
referred for CABG, and 22 (15%) lesions were
treated medically.
Conclusion: At a Veterans Administration
Hospital, FFR was performed in approximately
one out of four total catheterizations. FFR
documented lack of ischemia in about half of
the intermediate coronary lesions, and thus
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reduced the need for many revascularization
procedures.
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INTRODUCTION
Assessment of intermediate coronary lesions
(30–70% stenosis) by coronary angiogram has
been shown to be a poor predictor of the
hemodynamic significance of the lesion [1].
Earlier studies had suggested that fractional
flow reserve (FFR)-guided revascularization was
superior at reducing major cardiac adverse
outcomes when compared with
angiogram-guided revascularization [2–4]. The
5-year follow-up of the Fractional Flow Reserve
Versus Angiography for Multivessel Evaluation
(FAME; Clinicaltrials.gov identifier,
NCT00267774) trial demonstrated that an
FFR-guided approach is associated with a
similar risk of major events but with a lower
number of stented arteries and less resource use
[5]. FFR assessment during coronary
angiography is endorsed by the European
Society of Cardiology and the American
College of Cardiology for identification of
hemodynamically significant lesions when
non-invasive evidence of myocardial ischemia
is unavailable [6, 7]. Deferral of revascularization
is recommended for non-ischemic lesions [8, 9].
Despite the documented benefits of FFR, some
operators may not embrace the frequent use of
FFR. This might be especially true in a
fee-for-service system, where FFR could result
in deferral of revascularization. The Veterans
Health System is unique in that there is no
financial incentive to perform revascularization
procedures. Therefore, at a single-center
Veterans Administration Hospital, our
objectives were twofold. The first objective was
to determine how frequently FFR was
performed. The second objective was to
determine how FFR values would impact the
performance or deferral of revascularization,
especially within the gray zone.
METHODS
This was a single-center study that prospectively
entered all patients referred for cardiac
catheterization for any indication at the North
Florida/South Georgia Veterans Health System
from May 2012 until January 2014 into a
database. This database was established to
determine the frequency of FFR usage and how
FFR values impact revascularization decisions;
therefore, baseline characteristics and clinical
outcomes were not recorded. Institutional
Review Board approval was obtained prior to
conducting the study. FFR was defined as a
whole cardiac cycle pressure-derived index of
the maximum achievable blood flow in a
coronary artery with a stenosis expressed as a
ratio of maximum achievable blood flow if that
artery were normal [8, 10]. FFR was measured in
all intermediate coronary lesions (30–70%
stenosis) using a coronary pressure guide wire
(Volcano Corporation; San Diego, CA) at
maximal hyperemia induced by peripherally
administrated intravenous adenosine (140 lg/
kg/min for 2 min) or regadenoson (0.4 mg
bolus) at operator discretion. Based on the FFR
results, the lesions were categorized into three
different groups: FFR[0.80 (non-ischemic), FFR
0.75–0.80 (gray zone), and FFR\0.75
(ischemic). The decision to defer or proceed
with revascularization on the basis of FFR
measurement was left to the operator’s
judgment.
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RESULTS
A total of 1482 cardiac catheterizations were
performed during the study period. FFR was
performed in 347 (23%) of these procedures.
The total numbers of intermediate coronary
lesions evaluated with FFR were 429. The mean
FFR value was 0.79 (median = 0.80, interquartile
range 0.64–0.96). Among 211 non-ischemic
lesions, revascularization was deferred in 201
(95%). In the remainder of patients with
non-ischemic lesions, referral was placed for
coronary artery bypass grafting surgery (CABG)
for concomitant lesions in eight patients and
percutaneous coronary intervention (PCI) was
performed in two cases due to intravascular
ultrasound findings. In the gray-zone group (73
lesions), 35 (48%) lesions were treated with PCI,
11 (15%) lesions were referred for CABG, and 27
(37%) lesions were treated medically. In the
ischemic group (145 lesions), 82 (57%) lesions
were treated with PCI, 41 (28%) lesions were
referred for CABG, and 22 (15%) lesions were
treated medically. In the gray-zone group, the
most common reasons for deferring
revascularization included mild angina
symptoms, inadequate anti-angina therapy, or
high PCI complexity. In the ischemic group, the
most common reasons for deferring
revascularization included small vessel size (i.e.,
\2.25 mm) and/or diffuse lesions that markedly
increased the risk for restenosis, or high PCI
complexity. Figure 1 summarizes the percentage
of lesions in each group.
Fig. 1 Summary for the percentage of lesions in each
group. a Percentage of lesions in each fractional ﬂow reserve
category. Distribution of treatment (medical, revasculariza-
tion, or referral for CABG) in the non-ischemic group (b),
gray-zone group (c), and ischemic group (d). CABG
coronary artery bypass grafting surgery, PCI percutaneous
coronary intervention
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DISCUSSION
In the United States, the average use of FFR has
been reported to be as low as 6.1%, with more
FFR procedures performed in academic
institutions, particularly those with fellowship
programs [11]. FFR usage is affected by operator
expertise, reimbursement, and the availability
of necessary equipment. At our institution, FFR
was performed at a higher rate than previously
reported; however, as previously mentioned,
the Veterans Health System is unique since
there is no financial incentive to perform
revascularization procedures. Incorporating
FFR in revascularization decisions has been
demonstrated to result in fewer PCI procedures
[2, 12–14]. Our results showed that FFR usage
resulted in deferral of revascularization in
approximately half of the cases due to
non-ischemic lesions.
In the gray-zone group, approximately 63%
of the lesions either underwent PCI or referred
for CABG, which is slightly higher than prior
studies [15, 16]. Recent studies had suggested
increasing the sensitivity for detecting ischemia
(i.e., the threshold for revascularization
changed from FFR\0.75 to \0.80) [4]. We
observed that 37% of gray-zone lesions were
deferred revascularization which illustrates that
in real-life clinical practice there is still adequate
room for medical management and clinical
judgment for such lesions. In other words, an
FFR value \0.80 should not be an ‘automatic
license’ to perform revascularization.
Revascularization was deferred in the
gray-zone group mostly due to mild symptoms
and/or inadequate anti-angina therapy. In the
ischemic group, revascularization was deferred
infrequently (15%). This was mostly due to
anatomical concerns (characteristics that made
PCI high risk or significantly increased the risk
for restenosis).
This study was limited by being an
observational study conducted in a single
academic center. We did not report any
baseline characteristics or clinical outcome
data; however, this information would not be
considered particularly germane to the stated
objectives of this study. Moreover, this
information can be found in other reports.
Meta-analysis of observational studies has
documented similar outcomes associated with
deferral of non-ischemic left main lesions
compared with revascularization of ischemic
left main lesions. On the other hand, adverse
outcomes are low with deferral of
non-ischemic lesions compared with
revascularization of ischemic lesions for
non-left main lesions [9].
CONCLUSIONS
In a single-center practice that does not provide
a financial incentive for performing
revascularization procedures, FFR usage
occurred at a higher frequency than previously
reported (approximately one in four
catheterization procedures). Frequent use of
FFR documented lack of ischemia in about
half of the intermediate coronary lesions, and
thus reduced the need for many
revascularization procedures.
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